Temozolomide protects against the progression of glioblastoma via SOX4 downregulation by inhibiting the LINC00470‐mediated transcription factor EGR2

OBJECTIVE: Temozolomide is extensively applied in chemotherapy for glioblastoma with unclear exact action mechanisms. This article seeks to address the potential molecular mechanisms in temozolomide therapy for glioblastoma involving LINC00470. METHODS: Bioinformatics analysis was conducted to predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenyang, Wang, Ming, Ma, Wenjia, Liu, Ping, Zhang, Mingming, He, Jiarong, Cui, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352878/
https://www.ncbi.nlm.nih.gov/pubmed/36987665
http://dx.doi.org/10.1111/cns.14181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352878/
https://www.ncbi.nlm.nih.gov/pubmed/36987665
http://dx.doi.org/10.1111/cns.14181

Ejemplares similares